Protagenic Therapeutics, Inc.\new (PTIX) Liabilities and Shareholders Equity (2013 - 2026)
Protagenic Therapeutics, Inc.\new (PTIX) posted Liabilities and Shareholders Equity of $2.8 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 23.4% from the prior quarter.
Protagenic Therapeutics, Inc.\new (PTIX) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Protagenic Therapeutics, Inc.\new's Liabilities and Shareholders Equity came in at $3.65 million.
- Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -19.9% (FY2021 to FY2026).
- In prior fiscal years, Protagenic Therapeutics, Inc.\new's Liabilities and Shareholders Equity was $89,093 in FY2025, $1.96 million in FY2024 (-54.8%), $4.32 million in FY2023 (-46.2%) and $8.04 million in FY2022 (-27.3%).
- The fiscal Q1 2027 figure stands as the lowest quarterly Liabilities and Shareholders Equity since fiscal Q4 2025.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior fiscal quarters was $3.65 million (Q4 2026), $4.43 million (Q3 2026) and $5 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Protagenic Therapeutics, Inc.\new | 1.38 Mn | 1.38 Mn | - | 2.80 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.80 Mn |
| Mar 31, 2026 | 3.65 Mn |
| Dec 31, 2025 | 4.43 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | 89,093.00 |
| Dec 31, 2024 | 1.96 Mn |
| Sep 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 2.58 Mn |
| Dec 31, 2023 | 4.32 Mn |
| Sep 30, 2023 | 5.43 Mn |
| Jun 30, 2023 | 6.92 Mn |
| Mar 31, 2023 | 7.67 Mn |
| Dec 31, 2022 | 8.04 Mn |
| Sep 30, 2022 | 8.25 Mn |
| Jun 30, 2022 | 9.01 Mn |
| Mar 31, 2022 | 9.80 Mn |
| Dec 31, 2021 | 11.06 Mn |
| Sep 30, 2021 | 11.66 Mn |
| Jun 30, 2021 | 12.06 Mn |
Protagenic Therapeutics, Inc.\new Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PTIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();